Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 9/20 | 0.52 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30787188 | 1.00 | FDPS (0.52) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL30957878 | 1.00 | FDPS (0.52) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL30787364 | 1.00 | FDPS (0.52) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL14358450 | 1.00 | FDPS (0.52) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL10457259 | 1.00 | FDPS (0.52) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL10896959 | 1.00 | FDPS (0.52) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL3660932 | 1.00 | FDPS (0.52) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL12638365 | 1.00 | FDPS (0.52) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL21808818 | 1.00 | FDPS (0.52) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL30787260 | 1.00 | FDPS (0.52) | FDPSGGPS1TSHRTHRBSMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070042030-A1 | Preparation for the application of agents in mini-droplets | IDEA AG (DE) | 2007-02-22 | — | — | US | disclosed |
| US-6165500-A | Preparation for the application of agents in mini-droplets | IDEA AG (DE) | 2000-12-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070042030-A1 | Preparation for the application of agents in mini-droplets | FABP4, NPC1L1, LIPA | FDPS 1188/4885GGPS1 3084/4885TSHR 2808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.